BSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/28/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization16,309 mln
Float470 mln
EPS
0.90
Moderate
P / E
21.62
Premium valuation
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.26
Borderline
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.00
Debt-free
Business Description
Founded in 1988 and headquartered in Indore, India, Syncom Formulations (India) Limited is a pharmaceutical company that produces and distributes a broad range of medicines across domestic and international markets. Its product portfolio spans numerous therapeutic areas, including infections, heart conditions, skin care, digestive health, and child and women's health, available in forms such as tablets, capsules, injections, creams, and liquids. The company also operates in property rental and commodity trading, and markets a line of nutrition products under its Cratus brand.
